Cited by 550Gastrointestinal motility and disordersStatistical Methods in Clinical TrialsEthics in Clinical Research

The DOI matches its Crossref record; 147 of the 151 references it cites were found in a registry or an index.

Design of Treatment Trials for Functional Gastrointestinal Disorders

Irvine, E. Jan, Tack, Jan, Crowell, Michael D., Gwee, Kok Ann, Ke, Meiyun, Schmulson, Max J., Whitehead, William E., Spiegel, Brennan·2016·Gastroenterology

DOI 10.1053/j.gastro.2016.02.010

Open this paper in CoChat — free account

Abstract

This article summarizes recent progress and regulatory guidance on design of trials to assess the efficacy of new therapies for functional gastrointestinal disorders (FGIDs). The double-masked, placebo-controlled, parallel-group design remains the accepted standard for evaluating treatment efficacy. A control group is essential, and a detailed description of the randomization process and concealed allocation method must be included in the study report. The control will most often be placebo, but for therapeutic procedures and for behavioral treatment trials, respectively, a sham procedure and control intervention with similar expectation of benefit, but lacking the treatment principle, are recommended. Investigators should be aware of, and attempt to minimize, expectancy effects (placebo, nocebo, precebo). The primary analysis should be based on the proportion of patients in each treatment arm who satisfy a treatment responder definition or a prespecified clinically meaningful change in a patient-reported outcome measure. Data analysis should use the intention-to-treat principle. Reporting of results should follow the Consolidated Standards for Reporting Trials guidelines and include secondary outcome measures to support or explain the primary outcome and an analysis of harms data. Trials should be registered in a public location before initiation and results should be published regardless of outcome.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2016.02.010

Cites

147 of 147 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
The McGill Pain Questionnaire: Major properties and scoring methods
Melzack, R. (1975) · Pain · doi:10.1016/0304-3959(75)90044-5 · Cited by 6,873
Multilevel analysis : an introduction to basic and advanced multilevel modeling
Snijders, T. A. B., & Bosker, R. (1999) · Cited by 6,830
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
Measurement of health status
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
The MOS Short-form General Health Survey: Reliability and Validity in a Patient Population
Stewart, A. L., Hays, R. D., & Ware, J. E. (1988) · Medical Care · doi:10.1097/00005650-198807000-00007 · Cited by 3,339

Flagged first, then by citations

Show all 151 references

4 of the 151 references couldn’t be matched to a known paper.

Sorted by citations

Prebiotic effects: metabolic and health benefits
Roberfroid, M. B., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R. A., Rowland, I. R., Wolvers, D. A. W., Watzl, B., Szajewska, H., Stahl, B., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003363 · Cited by 2,170
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
Fukase, K., Kato, M., Kikuchi, S., Inoue, K., Uemura, N., Okamoto, S., Terao, S., Amagai, K., Hayashi, S., & Asaka, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61159-9 · Cited by 1,242
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome a double-blind, randomized, placebo-controlled study
Pimentel, M., Chow, E. J., & Lin, H. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07234.x · Cited by 670
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.
Ludvik, B., Giorgino, F., Jódar, E., Frias, J. P., Fernández Landó, L., Brown, K., Bray, R., & Rodríguez, Á. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01443-4 · Cited by 639
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).
Drossman, D. A., Toner, B. B., Whitehead, W. E., Diamant, N. E., Dalton, C. B., Duncan, S., Emmott, S., Proffitt, V., Akman, D., Frusciante, K., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00669-3 · Cited by 614
Self-citation
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
Böhn, L., Störsrud, S., Liljebo, T. M., Collin, L., Lindfors, P., Törnblom, H., & Simrén, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.054 · Cited by 628
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome
Staudacher, H. M., Lomer, M. C. E., Anderson, J. L., Barrett, J. S., Muir, J. G., Irving, P. M., & Whelan, K. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.159285 · Cited by 590
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial
Pimentel, M., Park, S., Mirocha, J., Kane, S. V., & Kong, Y. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00004 · Cited by 466
Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
Müller-Lissner, S. A., Fumagalli, I. A. L., Bardhan, K. D., Pace, F., Pecher, E., Nault, B., & Rüegg, P. C. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01094.x · Cited by 462
The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome
Creed, F., Fernandes, L., Guthrie, E., Palmer, S., Ratcliffe, J., Read, N., Rigby, C., Thompson, D., & Tomenson, B. (2003) · Gastroenterology · doi:10.1053/gast.2003.50055 · Cited by 443
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
Ford, A. C., Talley, N. J., Spiegel, B. M. R., Foxx-Orenstein, A. E., Schiller, L., Quigley, E. M. M., & Moayyedi, P. (2008) · BMJ · doi:10.1136/bmj.a2313 · Cited by 565
Self-citation
Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome
Chumpitazi, B. P., Cope, J. L., Hollister, E. B., Tsai, C. M., McMeans, A. R., Luna, R. A., Versalovic, J., & Shulman, R. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13286 · Cited by 436
Fiber and Functional Gastrointestinal Disorders
Eswaran, S. L., Muir, J. G., & Chey, W. D. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.63 · Cited by 451
A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species: a randomized controlled trial
Staudacher, H. M., Lomer, M. C. E., Farquharson, F. M., Louis, P., Fava, F., Franciosi, E., Scholz, M., Tuohy, K. M., Lindsay, J. O., Irving, P. M., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.010 · Cited by 430
Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis
Ford, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.148 · Cited by 405
Self-citation
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Ford, A. C., Moayyedi, P., Chey, W. D., Harris, L. A., Lacy, B. E., Saito, Y. A., & Quigley, E. M. M. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0084-x · Cited by 388
Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome
Poynard, T., Regimbeau, C., & Benhamou, Y. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00937.x · Cited by 406
Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT
Barichella, M., Pacchetti, C., Bolliri, C., Cassani, E., Iorio, L., Pusani, C., Pinelli, G., Privitera, G., Cesari, I., Faierman, S. A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003127 · Cited by 390
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota
KAJANDER, K., MYLLYLUOMA, E., RAJILIĆ‐STOJANOVIĆ, M., KYRÖNPALO, S., RASMUSSEN, M., JÄRVENPÄÄ, S., ZOETENDAL, E. G., DE VOS, W. M., VAPAATALO, H., & KORPELA, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03542.x · Cited by 367
Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial
GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
Brenner, D. M., Moeller, M. J., Chey, W. D., & Schoenfeld, P. S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.25 · Cited by 362
A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6‐month intervention
KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361
Systematic Review on the Management of Chronic Constipation in North America
Brandt, L. J., Prather, C. M., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P., & Talley, N. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50613_2.x · Cited by 344
Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome
Bijkerk, C. J., Muris, J. W. M., Knottnerus, J. A., Hoes, A. W., & de Wit, N. J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.0269-2813.2004.01862.x · Cited by 325
Randomized, Controlled Trial Shows Biofeedback to be Superior to Alternative Treatments for Patients with Pelvic Floor Dyssynergia-Type Constipation
Heymen, S., Scarlett, Y. V., Jones, K., Ringel, Y., Drossman, D. A., & Whitehead, W. E. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0814-9 · Cited by 323
Self-citation
The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials
Dimidi, E., Christodoulides, S., Fragkos, K. C., Scott, S. M., & Whelan, K. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.089151 · Cited by 316
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial
Bijkerk, C. J., de Wit, N. J., Muris, J. W. M., Whorwell, P. J., Knottnerus, J. A., & Hoes, A. W. (2009) · BMJ · doi:10.1136/bmj.b3154 · Cited by 312
A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel Syndrome
Camilleri, M., Chey, W. Y., Mayer, E. A., Northcutt, A. R., Heath, A. T., Dukes, G. E., McSorley, D., & Mangel, A. W. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.14.1733 · Cited by 302
The low FODMAP diet in the management of irritable bowel syndrome: an evidence‐based review of FODMAP restriction, reintroduction and personalisation in clinical practice
Whelan, K., Martin, L. D., Staudacher, H. M., & Lomer, M. C. E. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12530 · Cited by 322
“has been recommended by some as a primary outcome measurement in drug trials (34) and dietary trials ((34,41)).”
Background
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome
Tack, J. F., Broekaert, D., Fischler, B., Oudenhove, L. V., Gevers, A. M., & Janssens, J. (2006) · Gut · doi:10.1136/gut.2005.077503 · Cited by 289
Self-citation
A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation
Novick, J. S., Miner, P. B., Krause, R. A., Glebas, K., Bliesath, H., Ligozio, G., Rüegg, P. C., & Lefkowitz, M. P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01372.x · Cited by 288
Long term benefits of hypnotherapy for irritable bowel syndrome
Gonsalkorale, W. M., Miller, V, Afzal, A., & Whorwell, P. J. (2003) · Gut · doi:10.1136/gut.52.11.1623 · Cited by 283
The placebo effect in irritable bowel syndrome trials: a meta‐analysis1
Patel, S. M., Stason, W. B., Legedza, A., Ock, S. M., Kaptchuk, T. J., Conboy, L., Canenguez, K., Park, J. K., Kelly, E., Jacobson, E., et al. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00650.x · Cited by 285
Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome – A randomized controlled trial
Ljótsson, B., Falk, L., Vesterlund, A. W., Hedman, E., Lindfors, P., Rück, C., Hursti, T., Andréewitch, S., Jansson, L., Lindefors, N., et al. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.03.003 · Cited by 270
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome
Ducrotte, P. R. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i30.4012 · Cited by 273
Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
Ford, A. C., Brandt, L. J., Young, C., Chey, W. D., Foxx-Orenstein, A. E., & Moayyedi, P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.223 · Cited by 261
Systematic review: the effects of fibre in the management of chronic idiopathic constipation
Suares, N. C., & Ford, A. C. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04602.x · Cited by 259
Multicenter, Randomized, Placebo-Controlled Trial of Amitriptyline in Children With Functional Gastrointestinal Disorders
Saps, M., Youssef, N. N., Miranda, A., Nurko, S., Hyman, P. E., Cocjin, J. T., & Lorenzo, C. D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.060 · Cited by 253
A randomized double‐blind placebo‐controlled trial of Lactobacillus GG for abdominal pain disorders in children
GAWROŃSKA, A., DZIECHCIARZ, P., HORVATH, A., & SZAJEWSKA, H. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03175.x · Cited by 251
A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations
Craske, M. G., Wolitzky-Taylor, K. B., Labus, J., Wu, S., Frese, M., Mayer, E. A., & Naliboff, B. D. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.04.001 · Cited by 243
Health-Related Quality of Life and Health Care Costs in Severe, Refractory Irritable Bowel Syndrome
Creed, F. H., Ratcliffe, J., Fernandez, L., Tomenson, B., Palmer, S., Rigby, C., Guthrie, E., Read, N., & Thompson, D. G. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_2-200105011-00010 · Cited by 246
Randomized Controlled Trial Shows Biofeedback to be Superior to Pelvic Floor Exercises for Fecal Incontinence
Heymen, S., Scarlett, Y. V., Jones, K., Ringel, Y., Drossman, D. A., & Whitehead, W. E. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181b55455 · Cited by 244
Self-citation
Mechanisms and efficacy of dietary FODMAP restriction in IBS
Staudacher, H. M., Irving, P. M., Lomer, M. C. E., & Whelan, K. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.259 · Cited by 252
S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)
Layer, P., Andresen, V., Pehl, C., Allescher, H. ‐., Bischoff, S., Claßen, M., Enck, P., Frieling, T., Haag, S., Holtmann, G., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0029-1245976 · Cited by 236
Meta‐analysis: factors affecting placebo response rate in the irritable bowel syndrome
Ford, A. C., & Moayyedi, P. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04328.x · Cited by 226
Efficacy of alosetron in irritable bowel syndrome: a meta‐analysis of randomized controlled trials
Cremonini, F., Delgado‐Aros, S., & Camilleri, M. (2003) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2003.00389.x · Cited by 219
Acupuncture for treatment of irritable bowel syndrome
Manheimer, E. W., Cheng, K., Wieland, L. S., Min, L. S., Shen, X., Berman, B., & Lao, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005111.pub3 · Cited by 219
The Effect of a Multispecies Probiotic Mixture on the Symptoms and Fecal Microbiota in Diarrhea-dominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
Ki Cha, B., Mun Jung, S., Hwan Choi, C., Song, I.-D., Woong Lee, H., Joon Kim, H., Hyuk, J., Kyung Chang, S., Kim, K., Chung, W.-S., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31823712b1 · Cited by 216
Treatment of irritable bowel syndrome with herbal preparations: results of a double‐blind, randomized, placebo‐controlled, multi‐centre trial
Madisch, A., Holtmann, G., Plein, K., & Hotz, J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01859.x · Cited by 216
Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Andresen, V., Montori, V. M., Keller, J., West, C. P., Layer, P., & Camilleri, M. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.12.015 · Cited by 212
Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS
Bajor, A., Törnblom, H., Rudling, M., Ung, K., & Simrén, M. (2014) · Gut · doi:10.1136/gutjnl-2013-305965 · Cited by 215
STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study
von Arnim, U., Peitz, U., Vinson, B. R., Gundermann, K., & Malfertheiner, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01183.x · Cited by 206
Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood: Meta-analysis: Lactobacillus GG and abdominal pain-related functional disorders
Horvath, A., Dziechciarz, P., & Szajewska, H. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04665.x · Cited by 201
Tegaserod
Camilleri, M. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00925.x · Cited by 198
Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome
Lembo, T., Wright, R. A., Bagby, B., Decker, C., Gordon, S., Jhingran, P. M., & Carter, E. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04128.x · Cited by 191
Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease
Prince, A. C., Myers, C. E., Joyce, T., Irving, P. M., Lomer, M. C. E., & Whelan, K. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000708 · Cited by 190
Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome
Lackner, J. M., Jaccard, J., Keefer, L., Brenner, D. M., Firth, R. S., Gudleski, G. D., Hamilton, F. A., Katz, L. A., Krasner, S. S., Ma, C.-X., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.063 · Cited by 191
Adaptation of Bacteria to the Intestinal Niche: Probiotics and Gut Disorder
Dunne, C. P. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00010 · Cited by 183
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Xu, D., Chen, V. L., Steiner, C. A., Berinstein, J. A., Eswaran, S. L., Waljee, A. K., Higgins, P., & Owyang, C. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000198 · Cited by 181
“Global improvement was assessed either as response to the dichotomous question of global improvement of IBS symptoms or clinically meaningful improvement assessed by accepted integrative symptom questionnaires, such as IBS Severity Scoring System instrument and Functional Bowel Disease Symptom Index (25).”
BackgroundMethod
Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management
Du, Y., Rayner, C. K., Jones, K. L., Talley, N. J., & Horowitz, M. (2018) · Diabetes Care · doi:10.2337/dc17-1536 · Cited by 182
Psychological treatments for the management of irritable bowel syndrome
Zijdenbos, I. L., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Quartero, A. O. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006442.pub2 · Cited by 180
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility
Lackner, J. M., Jaccard, J., Krasner, S. S., Katz, L. A., Gudleski, G. D., & Holroyd, K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.004 · Cited by 176
Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview
Holtmann, G., Shah, A., & Morrison, M. (2018) · Digestive Diseases · doi:10.1159/000485409 · Cited by 163
Effect of Nortriptyline on Symptoms of Idiopathic Gastroparesis
Parkman, H. P., Natta, M. L. V., Abell, T. L., McCallum, R. W., Sarosiek, I., Nguyen, L. A. B., Snape, W. J., Koch, K. L., Hasler, W. L., Farrugia, G., et al. (2013) · JAMA · doi:10.1001/jama.2013.282833 · Cited by 175
How Does Cognitive Behavior Therapy for Irritable Bowel Syndrome Work? A Mediational Analysis of a Randomized Clinical Trial
Lackner, J. M., Jaccard, J., Krasner, S. S., Katz, L. A., Gudleski, G. D., & Blanchard, E. B. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.014 · Cited by 172
Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis
Black, C. J., Yuan, Y., Selinger, C. P., Camilleri, M., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30324-3 · Cited by 171
Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective
Tack, J. F., Fried, M., Houghton, L. A., SPICAK, J., & FISHER, G. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02938.x · Cited by 169
Self-citation
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders
Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160
Biofeedback treatment of fecal incontinence
Heymen, S., Jones, K. R., Ringel, Y., Scarlett, Y. V., & Whitehead, W. E. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234575 · Cited by 164
Self-citation
Therapeutic Effect of Lactobacillus acidophilus-SDC 2012, 2013 in Patients with Irritable Bowel Syndrome
Sinn, D. H., Song, J. H., Kim, H. J., Lee, J. H., Son, H. J., Chang, D. K., Kim, Y.-H., Kim, J. J., Rhee, J. C., & Rhee, P.-L. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0196-4 · Cited by 163
Evidence-based clinical practice guidelines for functional dyspepsia
Miwa, H., Kusano, M., Arisawa, T., Oshima, T., Kato, M., Joh, T., Suzuki, H., Tominaga, K., Nakada, K., Nagahara, A., et al. (2015) · Journal of gastroenterology · doi:10.1007/s00535-014-1022-3 · Cited by 163
Functional GI disorders: from animal models to drug development
Mayer, E. A., Bradesi, S., Chang, L., Spiegel, B. M. R., Bueller, J. A., & Naliboff, B. D. (2007) · Gut · doi:10.1136/gut.2006.101675 · Cited by 165
Self-citation
Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis
Zanten, S. J. O. V. V., Jones, M. J., Verlinden, M. H., & Talley, N. J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03521.x · Cited by 161
Diagnostic and Therapeutic Use of Proton Pump Inhibitors in Non-Cardiac Chest Pain: A Metaanalysis
Cremonini, F., Wise, J. L., Moayyedi, P., & Talley, N. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41657.x · Cited by 160
Alexithymia as Predictor of Treatment Outcome in Patients with Functional Gastrointestinal Disorders
Porcelli, P., Bagby, R. M., Taylor, G. J., Carne, M. D., Leandro, G., & Todarello, O. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000089064.13681.3b · Cited by 159
Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome
O'Keeffe, M., Jansen, C., Martin, L., Williams, M., Seamark, L., Staudacher, H. M., Irving, P. M., Whelan, K., & Lomer, M. C. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13154 · Cited by 181
“643 My life in relation to food and meals is close to my ideala 9 (45) 5 (25) 6 (30) 25 (29) 27 (32) 32 (38) .”
Audio-Recorded Guided Imagery Treatment Reduces Functional Abdominal Pain in Children: A Pilot Study
van Tilburg, M. A. L., Chitkara, D. K., Palsson, O. S., Turner, M., Blois‐Martin, N., Ulshen, M. H., & Whitehead, W. E. (2009) · PEDIATRICS · doi:10.1542/peds.2009-0028 · Cited by 156
Self-citation
Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy
Jones, H., Cooper, P., Miller, V., Brooks, N. H., & Whorwell, P. J. (2006) · Gut · doi:10.1136/gut.2005.086694 · Cited by 150
Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms
Francavilla, R., Píccolo, M. C., Francavilla, A., Polimeno, L., Semeraro, F., Cristofori, F., Castellaneta, S. P., Barone, M., Indrio, F., Gobbetti, M., et al. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001023 · Cited by 155
Irritable Bowel Syndrome
Ponti, F. D., & Tonini, M. (2001) · Drugs · doi:10.2165/00003495-200161030-00001 · Cited by 147
Systematic review with meta‐analysis: effect of fibre supplementation on chronic idiopathic constipation in adults
Christodoulides, S., Dimidi, E., Fragkos, K. C., Farmer, A. D., Whelan, K., & Scott, S. M. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13662 · Cited by 149
Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
Harvie, R. M., Chisholm, A. W., Bisanz, J. E., Burton, J. P., Herbison, P., Schultz, K., & Schultz, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4632 · Cited by 143
Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome
Ringel‐Kulka, T., Choi, C. H., Temas, D., Kim, A., Maier, D. M., Scott, K. P., Galanko, J. A., & Ringel, Y. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.220 · Cited by 142
Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors
von Wulffen, M. T., Talley, N. J., Hammer, J., MCMASTER, J. J., Rich, G. G., Shah, A., Koloski, N. A., Kendall, B. J., Jones, M., & Holtmann, G. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5343-6 · Cited by 140
Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial
Weydert, J. A., Shapiro, D., Acra, S. A., Monheim, C. J., Chambers, A. S., & Ball, T. M. (2006) · BMC Pediatrics · doi:10.1186/1471-2431-6-29 · Cited by 135
Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial
Cox, S. R., Prince, A. C., Myers, C. E., Irving, P. M., Lindsay, J. O., Lomer, M. C. E., & Whelan, K. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx073 · Cited by 142
Evidence-based clinical practice guidelines for functional dyspepsia 2021
Miwa, H., Nagahara, A., Asakawa, A., Arai, M., Oshima, T., Kasugai, K., Kamada, K., Suzuki, H., Tanaka, F., Tominaga, K., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-021-01843-7 · Cited by 144
Acupuncture for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
Manheimer, E. W., Wieland, L. S., Cheng, K., Li, S. M., Shen, X., Berman, B., & Lao, L. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.66 · Cited by 134
Spatial Patterns From High-Resolution Electrogastrography Correlate With Severity of Symptoms in Patients With Functional Dyspepsia and Gastroparesis
Gharibans, A. A., Coleman, T. P., Mousa, H. M., & Kunkel, D. C. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.039 · Cited by 132
Bowel Habit Subtypes and Temporal Patterns in Irritable Bowel Syndrome: Systematic Review
Guilera, M., Balboa, A., & Mearin, F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40674.x · Cited by 131
Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics
Bijkerk, C. J., de Wit, N. J., Muris, J. W. M., Jones, R. H., Knottnerus, J. A., & Hoes, A. W. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07158.x · Cited by 131
Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial
Basnayake, C., Kamm, M. A., Stanley, A., Wilson-O'Brien, A., Burrell, K., Lees-Trinca, I., Khera, A., Kantidakis, J., Wong, O., Fox, K., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30215-6 · Cited by 128
Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial
Talley, N. J., Kellow, J. E., Boyce, P. M., Tennant, C., Huskic, S., & Jones, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9830-4 · Cited by 130
Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
Norquist, J. M., Girman, C. J., Fehnel, S. E., DeMuro, C., & Santanello, N. C. (2011) · Quality of Life Research · doi:10.1007/s11136-011-0003-8 · Cited by 128
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation
Evans, B. W., Clark, W. K., Moore, D., & Whorwell, P. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003960.pub3 · Cited by 125
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials
Longstreth, G. F., Hawkey, C. J., Mayer, E. A., Jones, R. H., Naesdal, J., Wilson, I. K., Peacock, R. A., & Wiklund, I. K. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01010.x · Cited by 124
A Very Low-Carbohydrate Diet Improves Symptoms and Quality of Life in Diarrhea-Predominant Irritable Bowel Syndrome
Austin, G. L., Dalton, C. B., Hu, Y., Morris, C. B., Hankins, J. S., Weinland, S. R., Westman, E. C., Yancy, W. S., & Drossman, D. A. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.02.023 · Cited by 125

Authors: Irvine, E. J., Tack, J., Crowell, M. D., Gwee, K. A., Ke, M., Schmulson, M. J., Whitehead, W. E., & Spiegel, B.
Affiliations: St. Michael's Hospital (CA)
Universitair Ziekenhuis Leuven (BE)
Mayo Clinic (US)
National University of Singapore (SG)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Hospital General de México (MX)
University of North Carolina at Chapel Hill (US)
Cedars-Sinai Medical Center (US)
Corresponding author: Tack, Jan
ORCID: Tack, Jan
Crowell, Michael D.
Gwee, Kok Ann
Schmulson, Max J.
Whitehead, William E.
Spiegel, Brennan
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2016-05
Volume: 150
Issue: 6
Pages: 1469-1480.e1
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2016.02.010
OpenAlex: W2065994042
Cited by: 550
References: 151
Citations by year: 2026: 7 · 2025: 7 · 2024: 17 · 2023: 12 · 2022: 19 · 2021: 25 · 2020: 22 · 2019: 22 · 2018: 31 · 2017: 22 · 2016: 20
FWCI: 5.29
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
Keywords: functional gastrointestinal disorders, clinical trial design, sham procedure, expectancy effects, nocebo, patient-reported outcome measures, intention-to-treat analysis, CONSORT guidelines, clinical trial registration, regulatory guidelines
MeSH terms: Gastrointestinal Diseases, Research Design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Design of Treatment Trials for Functional Gastrointestinal Disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks